Skip to search formSkip to main contentSkip to account menu

Purpura, Thrombotic Thrombocytopenic

Known as: Purpura, Thrombotic Thrombocytopenic [Disease/Finding], Disease, Moschkowitz, Thrombopenic Purpura, Thrombotic 
An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical… 
National Institutes of Health

Related topics

Related topics

20 relations
ADAMTS13 geneBlood VesselDisseminated Intravascular CoagulationHematopoietic and Lymphoid Cell

Narrower (4)

Congenital Thrombotic Thrombocytopenic PurpuraFamilial Thrombotic Thrombocytopenic PurpuraHemolytic-Uremic SyndromeThrombotic thrombocytopenic purpura, acquired

Broader (3)

Thrombotic MicroangiopathiesVascular Diseasescirculatory disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
UvA-DARE ( Digital Academic Repository ) Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina : the CAPTURE study
  • 2017
  • Corpus ID: 30594110
Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or… 
Review
2008
Review
2008
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Discoveries during the past decade have revolutionized our understanding of idiopathic thrombotic thrombocytopenic purpura (TTP… 
Highly Cited
2004
Highly Cited
2004
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.
Therapeutic plasma exchange is an effective empiric treatment for thrombotic thrombocytopenic purpura (TTP), but how therapy… 
Review
2004
Review
2004
Recent advances in thrombotic thrombocytopenic purpura.
Thrombotic thrombocytopenic purpura (TTP) is characterized by microangiopathic hemolytic anemia and thrombocytopenia, accompanied… 
Highly Cited
2003
Highly Cited
2003
Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.
Acquired thrombotic thrombocytopenic purpura (TTP) has been linked to severe deficiency of ADAMTS-13 activity caused by… 
Review
2003
Review
2003
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases.
CONTEXT Thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS) share many clinical features and have… 
Highly Cited
2002
Highly Cited
2002
Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.
A severe deficiency in von Willebrand factor-cleaving protease (ADAMTS13) activity (< 5% that in normal plasma) has been observed… 
Review
1988
Review
1988
Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura
We reviewed the medical records and autopsy reports of 50 patients with systemic lupus erythematosus to determine the clinical… 
Highly Cited
1977
Highly Cited
1977
Treatment of thrombotic thrombocytopenic purpura with plasma.
Thrombotic thrombocytopenic purpura, the acute form of which is usually fatal, is characterized clinically by thrombocytopenia… 
Highly Cited
1977
Highly Cited
1977
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura.
Two patients with thrombotic thrombocytopenic purpura (TTP) have recovered completely after intensive plasmapheresis. The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)